logo

For the Inventor, By the Inventor

Madrid, Spain

Sebastian Hernandez

This inventor holds 19 USPTO granted patents, primarily in Antibiotic Production. Top assignee: Merck + Co., Inc.. Active years: 1976-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastian Hernandez. Retrieved from https://idiyas.com/inventor/sebastian-hernandez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 214(Granted Patents)


Company Filing History:

goldMedal19 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1976-1992

Loading Chart...
Areas of Expertise:
Antifungal Substances
Fermentation Process
Streptomyces
Thienamycin
Antibiotics
MSD A63A
Acetylthienamycin
Novel Antibiotics
Cultivation Techniques
Production Process
Antibiotic 890A
Sulfomycin
19 patents (USPTO):Explore Patents
1. 5130445 - Antifungal substances and process for their production (1992-07-14),
2. 5028537 - Novel antifungal substances and process for their production (1991-07-02),
3. 4575500 - Antifungal substances and process for their production (1986-03-11),
4. 4415669 - Substance and process for its production (1983-11-15),
5. 4385065 - Novel substances and process for their production (1983-05-24),
6. 4311693 - Discovery of MSD A63A, a new efrotomycin-line antibiotic fermentation (1982-01-19),
7. 4304867 - Culture of Streptomyces cattleya (1981-12-08),
8. 4264736 - Antibiotic 890A.sub.10 (1981-04-28),
9. 4264735 - Method of producing antibiotic 890A.sub.9 (1981-04-28),
10. 4235967 - Process for producing antibiotics by cultivation of Streptomyces (1980-11-25),
11. 4229534 - Acetylthienamycin production (1980-10-21),
12. 4168202 - Process for producing antibiotics (1979-09-18),
13. 4165379 - N-acetyl thienamycin (1979-08-21),
14. 4162324 - Antibiotics 890A.sub.1 and 890A.sub.3 (1979-07-24),
15. 4141986 - Antibiotics 890A.sub.2 and 890A.sub.5 (1979-02-27),

Title: Sebastian Hernandez: Innovator in Antifungal Compounds

Introduction: Sebastian Hernandez, a prominent inventor based in Madrid, Spain, has made significant contributions to the field of biotechnology with a focus on antimicrobial research. With an impressive portfolio that includes 19 patents, Hernandez is a leading figure in developing novel compounds that address critical health challenges.

Latest Patents: Among his latest innovations are groundbreaking patents related to antifungal substances and their production processes. These patents detail a series of macrolides isolated from the fermentation broth of a microorganism identified as MA-5000, which has been determined to be a strain of Streptomyces hygroscopicus. The structural analysis of these compounds has demonstrated their antifungal activity, showcasing their potential in combating fungal infections.

Career Highlights: Hernandez is currently associated with Merck & Company, Inc., a global leader in pharmaceuticals and biotechnology. His dedication to research and innovation has not only enhanced the company's portfolio but has also contributed significantly to the scientific community's understanding of antifungal agents.

Collaborations: Throughout his career, Sebastian has collaborated with esteemed colleagues, including Edward O Stapley and Robert T Goegelman. These partnerships have been instrumental in advancing research and driving the development of new, effective antifungal treatments.

Conclusion: Sebastian Hernandez's work in the field of antifungal substances positions him as a key innovator in medical biotechnology. His growing number of patents and ongoing contributions underscore the importance of collaborative research in developing solutions for health-related challenges. His dedication to innovation continues to inspire and pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…